PAVmed Inc. Warrant
PAVMW
PAVMW was delisted on the 28th of January, 2022.
3 hedge funds and large institutions have $13K invested in PAVmed Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
25% less funds holding
Funds holding: 4 → 3 (-1)
46% less capital invested
Capital invested by funds: $24K → $13K (-$11K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$611 |
| 2 |
AF
Allworth Financial
Folsom,
California
|
+$387 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$14.5K |
| 2 |
VF
Virtu Financial
New York
|
-$9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6K |
PAVMW Hedge Fund Activity: Q1 2021 in Review
3 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q1 2021, worth a combined $13K — down 46% from $24K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PAVMW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $611. The largest seller was Wolverine Asset Management, cutting an estimated $14.5K.
- 3 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q1 2021, down from 4 in Q4 2020.
- Funds reported $13K of PAVmed Inc. Warrant stock for Q1 2021, down 46% quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Warrant positions in Q1 2021 and 2 closed out, a net change of -1 holder.
- The largest PAVmed Inc. Warrant buyer in Q1 2021 was UBS Group, an estimated $611 added.
- The largest PAVmed Inc. Warrant seller in Q1 2021 was Wolverine Asset Management, an estimated $14.5K sold.
Based on aggregated 13F filings for Q1 2021.